Please login to the form below
Lars Rebien Sørensen becomes chairman of Novo Holdings
He will take up the new role 1 July
Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.
He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.
“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.
Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.
Featured jobs
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Systematic Reviewer - Oxford
-
Negotiable
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Business Director
-
Competitive Salary Offered
- Account Manager- Healthcare Advertising
-
Negotiable
- Business Development Director – Health Education
-
excellent commission
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Principal Health Economist - North-West
-
Negotiable
- Account Manager- Healthcare Advertising
-
Negotiable
-
Account Manager / Account Director
-
Competative
-
Senior Account Manager
-
Competitive Salary Offered
Subscribe to our email news alerts
- Healthcare excellence celebrated at 2018 HSJ Awards
- Better together when buying medicines? Taking stock of the BeNeLuxA initiative
- Report: Achieving launch excellence in the challenging healthcare markets of today
- What is blockchain and why should i care - Richard Springham
- NHS medicines optimisation milestone
- AZ and CRUK launch Cambridge genomics centre
PMHub
emotive.
emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
